Trademarkia Logo

Canada

C$
Trademark Search in Canada
MYXREDLIN-R

View On IC.GC.CA

MYXREDLIN-R
REGISTERED

on 29 Nov 2024

Last Applicant/ Owned by

Baxter International Inc.

One Baxter ParkwayDeerfield, IL 60015-4633

US

Serial Number

2175930 filed on 30th Mar 2022

Registration Number

TMA1272557 registered on 29th Nov 2024

Registration expiry Date

29th Nov 2034

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

MYXREDLIN-R

Trademark usage description

pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders namely hyperthyroidism, h Read More

Classification Information

Class [005]
Pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders namely hyperthyroidism, hypothyroidism, hyperglycemia, hypoglycemia, adrenal insufficiency and Cushing syndrome; pharmaceutical preparations containing insulin

Classification kind code

11

Mark Details

Serial Number

2175930

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 190
on 29th Nov 2024		Registration Pending
Submitted for opposition 55
on 29th Nov 2024		Registered
Submitted for opposition 42
on 11th Sept 2024		Advertised
Submitted for opposition 26
on 16th Aug 2024		Approved
Submitted for opposition 27
on 16th Aug 2024		Approval Notice Sent
Submitted for opposition 22
on 8th Aug 2024		Search Recorded
Submitted for opposition 287
on 18th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 30th Mar 2022		Filed
Submitted for opposition 1
on 30th Mar 2022		Created
Submitted for opposition 31
on 30th Mar 2022		Formalized